We could not find any results for:
Make sure your spelling is correct or try broadening your search.
BOSTON and SAN DIEGO, June 12, 2024 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational...
BOSTON and SAN DIEGO, June 06, 2024 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.46 | -1.95661420672 | 23.51 | 23.67 | 18.855 | 131256 | 20.27282957 | CS |
4 | 0.1 | 0.435729847495 | 22.95 | 27.714 | 18.855 | 157615 | 23.82325201 | CS |
12 | 5.05 | 28.0555555556 | 18 | 27.714 | 18 | 225078 | 23.27364607 | CS |
26 | 5.05 | 28.0555555556 | 18 | 27.714 | 18 | 225078 | 23.27364607 | CS |
52 | 5.05 | 28.0555555556 | 18 | 27.714 | 18 | 225078 | 23.27364607 | CS |
156 | 5.05 | 28.0555555556 | 18 | 27.714 | 18 | 225078 | 23.27364607 | CS |
260 | 5.05 | 28.0555555556 | 18 | 27.714 | 18 | 225078 | 23.27364607 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions